Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mylan And Upjohn Put A Price On $11.5bn Viatris Debt
Delayed Combination Of The Two Firms Is Set For Q4
Jun 19 2020
•
By
Dean Rudge
Upjohn has issued $11.5bn in senior notes to complete its separation and merger with Mylan • Source: Shutterstock
More from Deals
More from Business
